Day: June 9, 2021

Eatontown, NJ, June 09, 2021 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology company that through its subsidiaries and global distribution network provides financial technology, education tools, content, research, and management of digital asset technologies with a focus on Bitcoin mining and the new generation of digital assets, today announced that Ralph R. Valvano has been named Chief Financial Officer, effective June 7th, 2021. Mr. Valvano’s prior experience included the positions of CFO/COO of J.C. Flowers Asset Management, part of a $15 billion-dollar private equity firm, Financial and Operations Principal (FinOp) of J.C. Flowers Securities, a FINRA registered broker-dealer, and CFO of Flowers National Bank NA. Prior to that, Mr. Valvano held various roles at JPMorgan Chase & Co....

SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced that three abstracts have been accepted for presentation during the International Liver Congress™ 2021, the Annual Meeting of the European Association for the Study of the Liver (EASL) taking place virtually June 23-26, 2021. During the meeting, data from Assembly Bio’s three core inhibitor programs, vebicorvir (VBR), ABI-H2158 (2158) and ABI-H3733 (3733), will be featured in an oral presentation and two poster presentations. “We’re pleased to join our esteemed colleagues on the global stage that EASL affords to present data on our next-generation core inhibitors, 2158 and 3733, and to share further learnings...

CRANBURY, N.J., June 09, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will present at the Bank of America Securities 2021 Napa Biopharma Virtual Conference on Monday, June 14th. Details on the presentation can be found below.Bank of America Securities 2021 Napa Biopharma Virtual ConferenceDate: Monday, June 14, 2021Time: 2:30 PM ETAbout PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology...

LA JOLLA, Calif., June 09, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, announced today that it will present at the JMP Securities Life Sciences Conference, a virtual investor event, taking place June 16 and 17, 2021. Bruce Steel, Equillium’s chief executive officer, will provide a high-level overview of itolizumab’s mechanism of action and review each of the ongoing clinical programs, with a focus on topline data from the company’s EQUATE study in acute graft-versus-host disease, to be presented at EHA on Friday, June 11, 2021. Mr. Steel and other members of Equillium’s leadership team will be available for one-on-one meetings during the conference.Date:Time:Location: Wednesday, June 16, 202111:00 AM...

Program has driven reductions in hospital stays and medical expensesInks new partnerships with leading home-based care providers, Spiras Health and Upward Health NASHVILLE, Tenn., June 09, 2021 (GLOBE NEWSWIRE) — Today, Clover Health (Nasdaq: CLOV) (“Clover”), an innovative technology company committed to improving health equity for America’s underserved seniors, announces plans to scale its in-home primary care program, Clover Home Care, through the U.S. Centers for Medicare and Medicaid Services’ (CMS) new Direct Contracting model. The goal of Direct Contracting is to make the Medicare program more financially sustainable for taxpayers while improving health outcomes for beneficiaries, which aligns with the work of Clover Home Care. Clover Home Care is led by Dr. Kumar Dharmarajan, Associate Chief Medical Officer of Clover and...

EDISON, N.J., June 09, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and liver disease, is pleased to announce that it is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, according to a preliminary list of additions posted June 4. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “Being...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has established an at-the-market equity program (the “ATM Program”). The ATM Program allows the Company to issue and sell, at its discretion, up to $30,000,000 of common shares in the capital of the Company (the “Common Shares”) to the public from time to time through Cantor Fitzgerald Canada Corporation (the “Agent”), as sole agent, at the prevailing market price when issued, directly on the Toronto Stock Exchange or any other recognized marketplace upon which the Common Shares are listed or quoted or where the Common Shares are traded in Canada. The ATM Program will be effective...

EDMONTON, Alberta, June 09, 2021 (GLOBE NEWSWIRE) — Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), a company that develops, and invests in the research and development of, promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability, is pleased to announce that its distribution partner, Bunzl Canada, a division of Bunzl Distribution USA, LLC, has partnered with Tork®, a leading global health and hygiene company, to integrate Visionstate’s WANDA™ facility management solution (labelled as wandaNEXT™ by Bunzl Canada) and Tork’s smart dispenser data into Bunzl’s digital cleaning program at Queen’s University in Kingston, Ontario. wandaNEXT™, developed by Visionstate IoT and now in partnership with Bunzl, is a cleaning program management system with multiple IoT sensor-enabled...